Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
on GoodRx to $4 from $5 and kept an Equal Weight rating on the shares. In a 2026 outlook for the Healthcare Services sector, the firm highlighted a strong environment for market-beating returns within healthcare tech and provider stocks. In contrast, Morgan Stanley remains cautious on managed care and noted that after a weak 2025, the subsector continues to face a storm of regulatory shifts, reimbursement challenges, and rising service usage. Earlier on December 8, Barclays initiated coverage of GoodRx with an Underweight rating and $3 price target. This decision was made as the firm initiated coverage of the US healthcare technology and distribution sector with an overall neutral outlook, though the firm's sentiment varies significantly across specific sub-sectors. The firm expressed strong bullish conviction toward drug distributors and cited them as the most attractive segment within the group. In its Q3 2025 earnings report, GoodRx Holdings highlighted a total revenue of $196
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Surescripts and GoodRx Partner to Advance Patient Price TransparencyBusiness Wire
- BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 [Yahoo! Finance]Yahoo! Finance
- GoodRx (NASDAQ:GDRX) had its price target lowered by analysts at Citigroup Inc. from $5.00 to $4.50. They now have a "buy" rating on the stock.MarketBeat
- GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies [Yahoo! Finance]Yahoo! Finance
- GoodRx Launches RxSmartSaver at Giant Eagle PharmaciesBusiness Wire
GDRX
Earnings
- 11/4/25 - Beat
GDRX
Sec Filings
- 1/15/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- GDRX's page on the SEC website